These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17446061)

  • 21. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
    Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
    J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer.
    Kanao H; Enomoto T; Kimura T; Fujita M; Nakashima R; Ueda Y; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Tanigami A; Yoshino K; Murata Y
    Cancer Res; 2005 Oct; 65(19):8640-5. PubMed ID: 16204031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of hepatocyte growth factor activator inhibitor-1 (HAI-1) as a prognostic indicator in cervical cancer.
    Nakamura K; Abarzua F; Hongo A; Kodama J; Nasu Y; Kumon H; Hiramatsu Y
    Int J Oncol; 2009 Aug; 35(2):239-48. PubMed ID: 19578736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.
    Kwon GY; Ha H; Ahn G; Park SY; Huh SJ; Park W
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1150-6. PubMed ID: 17692475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
    Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
    BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
    Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
    Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma.
    Li J; Jia H; Xie L; Wang X; He H; Lin Y; Hu L
    Gynecol Oncol; 2009 Jul; 114(1):89-93. PubMed ID: 19359031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
    Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
    Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
    Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
    Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.
    Pilch H; Schäffer U; Schlenger K; Lautz A; Tanner B; Höckel M; Knapstein PG
    Gynecol Oncol; 1999 Jun; 73(3):415-21. PubMed ID: 10366470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression in early stage cervical cancer.
    Biewenga P; Buist MR; Moerland PD; Ver Loren van Themaat E; van Kampen AH; ten Kate FJ; Baas F
    Gynecol Oncol; 2008 Mar; 108(3):520-6. PubMed ID: 18191186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node metastases, not human telomerase reverse transcriptase or p53 proteins, as the strongest prognostic factor for survival in early stage cervical cancer.
    Tee YT; Wang PH; Yang SF; Ng SC; Ko JL; Chen GD; Chang H; Lin LY
    J Obstet Gynaecol Res; 2008 Dec; 34(6):1002-9. PubMed ID: 19012699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study.
    Kharaishvili G; Cizkova M; Bouchalova K; Mgebrishvili G; Kolar Z; Bouchal J
    J Clin Pathol; 2011 Nov; 64(11):977-82. PubMed ID: 21742751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumour invasion.
    Mukaratirwa S; van Ederen AM; Gruys E; Nederbragt H
    J Comp Pathol; 2004 Nov; 131(4):259-70. PubMed ID: 15511534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the serine protease hepsin and clinical outcome of human endometrial cancer.
    Matsuo T; Nakamura K; Takamoto N; Kodama J; Hongo A; Abrzua F; Nasu Y; Kumon H; Hiramatsu Y
    Anticancer Res; 2008; 28(1A):159-64. PubMed ID: 18383840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
    Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
    Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
    Qiao YH; Cheng J; Guo RX
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.